Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tiande Chemical Holdings Limited (0609.HK)
Weifang, CN
As an investment holding company, Tiande Chemical Holdings Limited focuses on the research, development, production, and global distribution of specialized chemical compounds. The company's operational footprint spans numerous international markets, including the People's Republic of China, India, the United States, Taiwan, and the United Kingdom. Its extensive range of primary chemical offerings features substances such as sodium cyanide, cyanoacetic acid and its derivatives, malonates, diethyl ethoxymethylenemalonate, EDTA acids and their salts, mono chloroacetic acid and related compounds, ethanol, tert-butanol, and cyanoacrylate monomers, along with various associated by-products. Beyond chemicals, Tiande also engages in the innovation, manufacturing, and commercialization of medical devices, as well as the production and sale of adhesive solutions. These diverse products are crucial for the synthesis of pharmaceuticals, pesticides, bonding agents, sealants, flavorings, and aromatic substances. Established in 1997, the company is based in Weifang, PRC, and functions as a subsidiary of Cheerhill Group Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -3.97% | -4.72% | -23.42% | -18.79% | -15.38% | +7.08% | -38.89% | +75.36% | -11.03% | +80.60% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+1.2% Q4'25: +3.9% (vs Q4'23)
-
EPS growth Chemicals: +11.7%-8.6% Q4'25: -40.6% (vs Q4'23)
-
FCF margin FCF growth · Chemicals: +41.7%+5.3% ★ Q4'25: +14.1% (vs Q4'23)
-
EBIT margin Chemicals: +7.1%+1.9% Q4'25: +1.4% (vs Q4'23)
-
ROIC Chemicals: +3.4%+1.2% Q4'25: +2.3% (vs Q4'23)
-
Share dilution Chemicals: +0.0%+0.4% Q4'25: +0.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.49× ★ Q4'25: 0.76× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.12B
est: 1.53B (-26.5%)
|
1.27B
est: 1.20B (+5.5%)
|
1.41B
est: 1.54B (-8.7%)
|
1.18B
est: 1.12B (+5.2%)
|
1.38B
est: 1.27B (+8.6%)
|
1.36B
est: 1.33B (+1.9%)
|
2.58B
est: 2.16B (+19.4%)
|
3.52B
est: 5.01B (-29.8%)
|
2.08B
est: 3.44B (-39.4%)
|
1.87B
est: 3.88B (-51.8%)
|
1.90B
est: 4.05B (-53.2%)
|
| EBITDA |
306.14M
est: 323.44M (-5.3%)
|
383.21M
est: 253.74M (+51.0%)
|
253.08M
est: 326.11M (-22.4%)
|
34.13M
est: 237.08M (-85.6%)
|
156.02M
est: 269.02M (-42.0%)
|
144.80M
est: 282.22M (-48.7%)
|
678.07M
est: 457.77M (+48.1%)
|
1.40B
est: 1.06B (+31.6%)
|
436.44M
est: 726.54M (-39.9%)
|
154.21M
est: 830.53M (-81.4%)
|
224.43M
est: 865.70M (-74.1%)
|
| EBIT |
236.78M
est: 229.29M (+3.3%)
|
302.79M
est: 179.88M (+68.3%)
|
162.84M
est: 231.19M (-29.6%)
|
-69.30M
est: 168.08M (-141.2%)
|
44.51M
est: 190.72M (-76.7%)
|
30.93M
est: 200.07M (-84.5%)
|
554.55M
est: 324.52M (+70.9%)
|
1.27B
est: 751.86M (+68.7%)
|
298.28M
est: 515.06M (-42.1%)
|
18.55M
est: 579.68M (-96.8%)
|
35.92M
est: 604.23M (-94.1%)
|
| Net Income |
172.37M
est: 333.09M (-48.3%)
|
219.60M
est: 236.73M (-7.2%)
|
101.56M
est: 335.84M (-69.8%)
|
-61.06M
est: 221.19M (-127.6%)
|
21.51M
est: 250.71M (-91.4%)
|
94.82M
est: 256.58M (-63.0%)
|
379.65M
est: 226.51M (+67.6%)
|
870.92M
est: 856.99M (+1.6%)
|
211.07M
est: 637.28M (-66.9%)
|
66.88M
est: 775.97M (-91.4%)
|
62.50M
est: 849.38M (-92.6%)
|
| SGA |
80.11M
est: 139.99M (-42.8%)
|
93.51M
est: 109.82M (-14.9%)
|
119.81M
est: 141.14M (-15.1%)
|
123.00M
est: 102.61M (+19.9%)
|
175.73M
est: 116.44M (+50.9%)
|
150.20M
est: 122.15M (+23.0%)
|
242.30M
est: 198.13M (+22.3%)
|
209.99M
est: 459.02M (-54.3%)
|
171.15M
est: 314.45M (-45.6%)
|
208.93M
est: 349.33M (-40.2%)
|
194.46M
est: 364.12M (-46.6%)
|
| EPS |
0.20
est: 0.38 (-47.5%)
|
0.26
est: 0.27 (-4.0%)
|
0.12
est: 0.38 (-68.8%)
|
-0.07
est: 0.25 (-128.3%)
|
0.03
est: 0.29 (-91.2%)
|
0.11
est: 0.29 (-62.5%)
|
0.45
est: 0.26 (+73.7%)
|
1.01
est: 0.98 (+3.0%)
|
0.24
est: 0.73 (-67.1%)
|
0.08
est: 0.88 (-91.3%)
|
0.07
est: 0.97 (-92.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aobo Dou | Executive Director | 1M | male |
| Yang Liu | Executive Chairman | 1M | male |
| Xiaohua Chen | GM & Executive Director | 1M | male |
| Wai Chun Lau HKICPA ACCA | Financial Controller & Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0609.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
